Kiai Parsa purchased $529K of MED (indirect holdings)
Kiai Parsa purchased 43,150 indirectly-held shares of MEDIFAST INC (MED) at $12.26 ($0.53M total) across 2 trades on 2026-08-26.
How this was made
The 30-second read
Why it matters
The insider buy may attract short‑term interest but is unlikely to drive major price movement.
Market read
A modest insider purchase; relevant for traders monitoring MED's insider activity.
What to watch
The transaction size is small relative to MED's market cap and may not move the stock.
Background
Form 4 filings disclose insider trades; a director purchase is often viewed as a confidence indicator.
Ticker impact
Director Kiai Parsa bought 43,150 shares of MED for $529K, increasing his stake to 20,270 shares.
Potential modest upside of 1‑2% as the market digests the insider buy.
A $529K insider purchase by a director is material for a mid‑cap stock, but the amount is modest relative to float.
Market effects
Minimal impact on the healthcare services sector.
U.S. market only; no broader regional effect.
Limited to investors tracking MED.
Counterpoint
The purchase could be a routine portfolio rebalancing rather than a bullish signal.
Key entities
- CompanyMEDIFAST Inc.
Provider of medication adherence solutions.
- PersonKiai Parsa
Director of MEDIFAST Inc.
